Loading...
NPI 1184891525 · Oklahoma City, OK · Public Health or Welfare Agency
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
State Of Oklahoma is a public health or welfare agency provider located in Oklahoma City, Oklahoma. This profile covers 15 Medicare and 22 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | State Of Oklahoma |
| Address | 123 Robert S Kerr Ave |
| City | Oklahoma City |
| State | OK |
| ZIP | 73102 |
| Taxonomy | Public Health or Welfare Agency |
| NPI Enumerated | May 14, 2008 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $546.3K |
| Medicaid | $162.5K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
15 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 2,110 | $80 | $170.9K |
| G0008 | Administration of influenza virus vaccine | 4,510 | $30 | $126.4K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 4,330 | $20 | $90.8K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 2,020 | $40 | $76.6K |
| 0134A | N/A | 960 | $40 | $36.3K |
| 0124A | N/A | 580 | $40 | $21.9K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 40 | $230 | $10.3K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 80 | $60 | $5K |
| G0009 | Administration of pneumococcal vaccine | 70 | $30 | $1.8K |
| 90732 | The provider intramuscularly or subcutaneously injects pneumococcal polysaccharide vaccine in an individual two years or older. This vaccine provides protection against meningitis and pneumonia that… | 10 | $120 | $1.5K |
Showing 1–10 of 15
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
22 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| T1001 | Nursing assessment / evaluation | 3,460 | $40 | $135.1K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 330 | $20 | $6K |
| 96127 | The provider performs a brief emotional/behavioral assessment of the patient using a standardized instrument (such as a recognized form). The provider scores and documents the assessment. | 1,030 | $1 | $4.1K |
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 80 | $40 | $3K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 360 | $10 | $2.9K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 150 | $10 | $1.7K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 20 | $80 | $1.6K |
| 81025 | The lab analyst performs the pregnancy test on a urine specimen using a methodology or kit that the analyst can read visually for a direct readout. | 200 | $10 | $1.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 10 | $80 | $1.1K |
| 90656 | This code represents a preservative–free trivalent influenza vaccine product containing split virus components. It is administered into the muscle in a 0.5 mL dosage. | 170 | $10 | $1K |
Showing 1–10 of 22
How this provider's Medicaid billing volume and revenue compare to other Oklahoma providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Oklahoma median
22 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| T1001 | Nursing assessment / evaluation | 4 | 20 | 310 | $60 | $415K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,655 | 1,750 | 870 | $70 | $254.4K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 42 | 50 | 170 | $30 | $163.4K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 42 | 50 | 200 | $30 | $163.3K |
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 71 | 110 | 170 | $40 | $50.9K |
| 92588 | The provider performs this noninvasive, diagnostic test to help detect inner ear abnormalities to identify such conditions as functional hearing loss or differentiate between sensory and neural… | 13 | 10 | 190 | $30 | $47.8K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 188 | 420 | 240 | $20 | $39.7K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 519 | 550 | 220 | $30 | $31.9K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 5 | 10 | 110 | $20 | $29.9K |
| 92587 | Code 92587 is in the Medicine/Special Otorhinolaryngologic Services Section. It involves special procedures of the ears/nose/throat. This code is for screening purposes with interpretation and… | 49 | 50 | 400 | $20 | $26.5K |
Showing 1–10 of 22
Other providers in the same ZIP code as State Of Oklahoma, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.